LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL

Overview of attention for article published in Cancer Cell, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 55 X users

Readers on

mendeley: 113 Mendeley

So far, Altmetric has seen 67 X posts from 55 X users, with an upper bound of 322,787 followers.

The authors of "LMO2 Confers Synthetic Lethality to PARP Inhibitio…" (https://t.co/dLy5cw2qWc) included RRIDs in their paper! Thank you for making your #methodsmatter. #RRID

RT @cancerSL: LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL. https://t.co/H3h4adpoa4

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL. https://t.co/H3h4adpoa4

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL https://t.co/0iQ5LzEb0C

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 63 additional X posts.